The Optimum Time for Preoxygenation Based on Body Mass Index
NCT ID: NCT01114932
Last Updated: 2012-02-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
75 participants
OBSERVATIONAL
2007-07-31
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Obesity in the Aged
NCT05028309
Evaluation of the Accuracy of a Computer Vision-based Tool for Assessment of Total Body Fat Percentage
NCT04854421
Subcutaneous Fat Reduction in the Submental Area
NCT02298322
Impact of Thoracic Duct Ligation on Postoperative Weight Reduction in Obese Patients Receiving Minimally Invasive Lung Surgery: A Clinical Investigation
NCT06995599
Transdisciplinary Intervention for Obesity Hypoventilation Syndrome
NCT07020689
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Facial hair and mask fit are recorded to assess possible failure of an optimal facemask seal. End-tidal carbon dioxide (FE'CO2) is also measured to ensure an adequate facemask seal. Anxiety can increase the respiratory rate, heart rate and affect patient compliance with a fitted facemask. All of the aforementioned values are recorded to assess reasons for possible failure of the preoxygenation technique and inaccurate results.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BMI-I
Patients with BMI values between 18.5-24.9
No interventions assigned to this group
BMI-II
Patients with BMI values between 25-29.9
No interventions assigned to this group
BMI-III
Patients with BMI values between 30-49.9
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants classified as ASA 1 or 2
* Participants capable of understanding and signing an informed consent
Exclusion Criteria
* History of smoking (smoking can affect pulmonary function and oxygen carrying capacity)
* Acute substance abuse (substance abuse can affect respiratory function).
* Maxillofacial abnormalities which would interfere with proper face mask seal.
18 Years
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cedars-Sinai Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Roya Yumul, M.D.,PhD.
Residency program director, Department of anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Roya Yumul, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars Sinai Medical Center
Los Angeles, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pro00011544
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.